Corcept Therapeutics Inc

XNAS: CORT

Expensive Performer

Download real time

56.50 -1.38 (-2.38%)

171.11% Gain from 52W Low

722.6K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

5,960.9

Market Cap

High in industry

0.1

Beta 1Year

Very Low volatility

Corcept Therapeutics Inc - CORT - stock price prediction, stock price target, analyst ratings from 4 analysts

Corcept Therapeutics Inc has a share price target of US$ 100, revenue growth forecast of 34.1%, and profit growth estimate of 59.6% for FY25, based on top 4 analyst calls.

Forecaster Screeners